Ann: POSITIVE TOP-LINE RESULTS FROM PRECLINICAL STUDY IN ARDS, page-43

First 43 Last

Share
Profile

Follow
oxxa23

6,027 Posts.

1160

13/10/21

13:55

Post #: 56767946
Share

Originally posted by slura ↑

Think you missed on the pros

* Revenue starting now not in another 3 years.

To me it was crystal clear 18 months ago when Covid was in the early stages, the cytokine storm and the bio markers causing the inflammation were the same that iPPS downregulates. I even brought it up here and said we should be going down the pathway of using iPPS as a treatment for Covid and it’s after effects. Even early on it was very apparent that long Covid existed.

Here we are, some 18 months later with results for 6 mice. Don’t get me wrong, they are great results, but this is an area that has fast track written all over it with EUA available for breakthrough Covid treatments. We salivate here every day and week about getting OA fast tracked but in the meantime we let a huge opportunity slip under our noses.

Right now we could have been signing contracts with governments for the treatment of Covid and moving into meaningful revenue which could fund us all the way through our OA trials if we had an aggressive approach.

Expand

Not so sure fast track for after effects would be as great as the fast tracking to save lives from covid.. but, I understand what you're saying...

Risk is letting a big phara too close to a platform could lead them to greater insight and file more and more patents for ipps before PAR can I guess... but, then again... a win is a win...

Realistically, without this sort of animal trials results what big pharma would even go close to hanfing over money to par for this? Not one is my guess... they don't throw money at a hunch..
I thibk now or post during/post phase one maybe... but not 18 months ago

Last edited by oxxa23: 13/10/21

PAR Price at posting: $1.91 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

What's causing the cost-of-living crisis, and how to navigate it

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t